BG98050A - Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат - Google Patents

Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат Download PDF

Info

Publication number
BG98050A
BG98050A BG98050A BG9805093A BG98050A BG 98050 A BG98050 A BG 98050A BG 98050 A BG98050 A BG 98050A BG 9805093 A BG9805093 A BG 9805093A BG 98050 A BG98050 A BG 98050A
Authority
BG
Bulgaria
Prior art keywords
salts
oxoethyl
cyclohexane
carboxylic acid
carbonyl
Prior art date
Application number
BG98050A
Other languages
Bulgarian (bg)
English (en)
Inventor
Raffaello Giorgi
Alessandro Subissi
Luigi Turbanti
Original Assignee
Laboratori Guidotti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti S.P.A. filed Critical Laboratori Guidotti S.P.A.
Publication of BG98050A publication Critical patent/BG98050A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
BG98050A 1991-12-23 1993-08-18 Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат BG98050A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI913448A IT1252708B (it) 1991-12-23 1991-12-23 Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
PCT/EP1992/002903 WO1993013056A1 (en) 1991-12-23 1992-12-12 Stable salts of (+)-(1s,2r)-2-[[n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BG98050A true BG98050A (bg) 1994-04-29

Family

ID=11361409

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98050A BG98050A (bg) 1991-12-23 1993-08-18 Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат

Country Status (26)

Country Link
EP (1) EP0575572A1 (xx)
JP (1) JPH06506002A (xx)
CN (1) CN1079474A (xx)
AU (1) AU657591B2 (xx)
BG (1) BG98050A (xx)
BR (1) BR9205652A (xx)
CA (1) CA2104372A1 (xx)
CZ (1) CZ379692A3 (xx)
EE (1) EE9400006A (xx)
FI (1) FI933685A0 (xx)
HR (1) HRP921454A2 (xx)
HU (1) HUT69287A (xx)
IT (1) IT1252708B (xx)
LV (1) LV10426B (xx)
MA (1) MA22749A1 (xx)
MX (1) MX9207543A (xx)
NZ (1) NZ245547A (xx)
PL (1) PL169086B1 (xx)
PT (1) PT101156A (xx)
RU (1) RU2079489C1 (xx)
SI (1) SI9200409A (xx)
SK (1) SK379692A3 (xx)
TN (1) TNSN92117A1 (xx)
WO (1) WO1993013056A1 (xx)
YU (1) YU110892A (xx)
ZA (1) ZA9210004B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264860B1 (it) * 1993-06-21 1996-10-17 Guidotti & C Spa Labor Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
FR2817241B1 (fr) 2000-11-30 2003-03-07 Cebal Tube aluminium avec embout secable
WO2008042146A1 (en) * 2006-09-28 2008-04-10 Merck & Co., Inc. Amine base salts of saha and polymorphs thereof
WO2021221984A1 (en) * 2020-04-27 2021-11-04 Carter-Hoffmann, Llc Door movement system for cabinet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1224627B (it) * 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.

Also Published As

Publication number Publication date
PL169086B1 (pl) 1996-05-31
ITMI913448A0 (it) 1991-12-23
RU2079489C1 (ru) 1997-05-20
CZ379692A3 (en) 1993-09-15
TNSN92117A1 (fr) 1993-06-08
MX9207543A (es) 1993-08-01
PT101156A (pt) 1994-06-30
EP0575572A1 (en) 1993-12-29
JPH06506002A (ja) 1994-07-07
ITMI913448A1 (it) 1993-06-23
HRP921454A2 (en) 1995-02-28
MA22749A1 (fr) 1993-07-01
BR9205652A (pt) 1994-05-03
NZ245547A (en) 1995-12-21
CN1079474A (zh) 1993-12-15
HU9302389D0 (en) 1993-11-29
CA2104372A1 (en) 1993-06-24
FI933685A (fi) 1993-08-20
IT1252708B (it) 1995-06-26
AU3087192A (en) 1993-07-28
LV10426A (lv) 1995-02-20
SK379692A3 (en) 1995-04-12
YU110892A (sh) 1996-01-08
EE9400006A (et) 1995-12-15
SI9200409A (en) 1993-09-30
HUT69287A (en) 1995-09-28
WO1993013056A1 (en) 1993-07-08
FI933685A0 (fi) 1993-08-20
PL297118A1 (en) 1993-09-06
AU657591B2 (en) 1995-03-16
LV10426B (en) 1995-08-20
ZA9210004B (en) 1993-12-13

Similar Documents

Publication Publication Date Title
AU634319B2 (en) Amino acid derivatives
AU2009202389B2 (en) Perindopril
US4558065A (en) Derivatives of tricyclic aminoacids, processes for their preparation, agents containing these compounds and their use, and new bicyclic aminoacids as intermediates and processes for their preparation
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
WO1989007610A1 (en) RENIN INHIBITORS CONTAINING alpha-HETEROATOM AMINO ACIDS
NZ206574A (en) 1-(n-(1-carboxyalkyl)-alpha-aminoalkanoyl)-octahydro2s,3as,8as-cyclohepta(b)pyrrol-2-ylcarboxylic acid derivatives
DE60221508T2 (de) Aminosäurederivate als hiv-protease-inhibitoren
FR2758328A1 (fr) Nouvelles amines aromatiques derivees d'amines cycliques utiles comme medicaments
US4216209A (en) Tripeptide angiotensin converting enzyme inhibitors
BG98050A (bg) Устойчиви соли на (+)-(1s,2r)-2-//n-(2-хидроксиламино-2- оксоетил)-n-метил-амино/карбонил/циклохексан-1-карбонова киселина, метод за получаването им и фармацевтични състави, в които те се съдържат
KR100209118B1 (ko) 벤즈아미드 유도체
US4322436A (en) Novel substituted phenylacetic acid amide compounds
FR2471972A1 (fr) Tetrapeptides homologues des enkephalines, leur preparation et leur utilisation therapeutique
GB2077719A (en) (N-(Cycloalkyl)amino acid compounds and compositions containing same
CA2164296C (en) Heterocyclic chemistry
EP0712838B1 (en) Acylphenylglycine derivative and preventive and remedy for diseases caused by increased collagenase activity containing said compound as active ingredient
WO1989000165A1 (en) Orally active antiandrogens
JP3254238B2 (ja) ホモキラルα−アミノアルデヒドのジアステレオ選択的な還元的ピナコールカップリング法
US4370494A (en) Converting enzyme inhibitors
US4386075A (en) Renally active tetrapeptides
US20060019951A1 (en) Vacuolins
JPH0662671B2 (ja) プロリン誘導体
EP0103927B1 (en) Converting enzyme inhibitors
JP3142993B2 (ja) 水溶性ベナスタチン誘導体及びその薬学的用途
CA2369654A1 (en) N-substituted-n'-substituted urea derivatives and pharmaceutical compositions containing said derivatives